HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janko Kos Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

2/2011Cystatin C in sera of patients with aggressive non-Hodgkin B-cell lymphoma.
4/2007Cystatin C as a potential marker for relapse in patients with non-Hodgkin B-cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Janko Kos Research Topics

Disease

79Neoplasms (Cancer)
04/2024 - 01/2000
24Neoplasm Metastasis (Metastasis)
03/2022 - 11/2002
12Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024 - 09/2012
10Alzheimer Disease (Alzheimer's Disease)
03/2019 - 08/2013
9Pathologic Processes
01/2022 - 04/2006
8Inflammation (Inflammations)
04/2024 - 08/2006
7Glioblastoma (Glioblastoma Multiforme)
02/2022 - 05/2002
7Breast Neoplasms (Breast Cancer)
01/2022 - 01/2000
6Glioma (Gliomas)
02/2022 - 05/2002
5Parkinson Disease (Parkinson's Disease)
05/2024 - 07/2014
5Prostatic Neoplasms (Prostate Cancer)
05/2020 - 12/2011
4Neuroblastoma
01/2022 - 01/2010
4Neuroinflammatory Diseases
11/2021 - 01/2017
4Brain Neoplasms (Brain Tumor)
10/2021 - 01/2000
4Infections
01/2014 - 08/2009
4Squamous Cell Carcinoma of Head and Neck
11/2013 - 06/2004
4Carcinoma (Carcinomatosis)
08/2007 - 05/2003
3Disease Progression
01/2022 - 08/2007
3Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 09/2012
3Carcinogenesis
01/2013 - 05/2004
2Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 07/2014
2Atherosclerosis
07/2019 - 10/2013
2Fibrosarcoma
08/2017 - 08/2015
2B-Cell Lymphoma (Lymphoma, B Cell)
02/2011 - 04/2007
2Ovarian Neoplasms (Ovarian Cancer)
07/2010 - 05/2010
2Astrocytoma (Pilocytic Astrocytoma)
12/2009 - 05/2002
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2006 - 05/2003
2Lung Neoplasms (Lung Cancer)
05/2005 - 05/2003
1Immune System Diseases (Immune Disorders)
02/2023
1Autoimmune Diseases (Autoimmune Disease)
02/2023
1COVID-19
01/2023

Drug/Important Bio-Agent (IBA)

48CathepsinsIBA
04/2024 - 01/2002
32Cysteine (L-Cysteine)FDA Link
02/2023 - 01/2002
25Peptide Hydrolases (Proteases)FDA Link
04/2022 - 05/2002
21Cathepsin BIBA
01/2023 - 01/2000
18Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2002
14Cysteine Proteases (Cysteine Protease)IBA
07/2019 - 01/2000
10CystatinsIBA
12/2023 - 05/2002
8Phosphopyruvate Hydratase (Enolase)IBA
05/2024 - 01/2010
8nitroxolineIBA
01/2023 - 01/2013
8Protease Inhibitors (Protease Inhibitor)IBA
01/2022 - 05/2002
8Cystatin CIBA
03/2019 - 06/2004
8Cystatin AIBA
11/2013 - 01/2000
7ButyrylcholinesteraseIBA
05/2023 - 10/2014
7CarboxypeptidasesIBA
02/2022 - 08/2006
7Biomarkers (Surrogate Marker)IBA
07/2019 - 01/2002
6LigandsIBA
05/2023 - 01/2015
6EnzymesIBA
01/2022 - 01/2002
6AntibodiesIBA
03/2020 - 01/2000
5Messenger RNA (mRNA)IBA
10/2021 - 01/2000
5Monoclonal AntibodiesIBA
08/2008 - 11/2002
4Anti-Infective Agents (Microbicides)IBA
01/2023 - 08/2017
4Cathepsin LIBA
10/2021 - 01/2002
4cathepsin SIBA
07/2019 - 01/2009
3Oxidopamine (6 Hydroxydopamine)IBA
05/2023 - 07/2014
3IntegrinsIBA
03/2022 - 01/2013
3Monoamine Oxidase (MAO)IBA
01/2022 - 01/2017
3AntigensIBA
01/2021 - 01/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 12/2018
3Cholinergic Agents (Cholinergics)IBA
11/2018 - 12/2016
3Amyloid (Amyloid Fibrils)IBA
01/2018 - 08/2013
3Profilins (Profilin)IBA
04/2015 - 01/2013
3Extracellular Matrix ProteinsIBA
07/2014 - 11/2002
3Anti-Bacterial Agents (Antibiotics)IBA
01/2014 - 08/2009
3Cathepsin HIBA
01/2013 - 01/2009
3Cystatin BIBA
05/2011 - 01/2002
3Cysteine Proteinase InhibitorsIBA
04/2007 - 06/2004
2Hormones (Hormone)IBA
03/2022 - 12/2018
2InterferonsIBA
03/2020 - 01/2020
2Chimeric Antigen ReceptorsIBA
03/2020 - 01/2020
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2018 - 12/2015
2Cathepsin KIBA
10/2018 - 10/2018
2CollagenIBA
01/2018 - 08/2015
2CytokinesIBA
12/2015 - 12/2011
2ChemokinesIBA
12/2015 - 04/2015
2EndopeptidasesIBA
08/2015 - 05/2002
2RNA (Ribonucleic Acid)IBA
04/2015 - 05/2002
2SolutionsIBA
05/2012 - 12/2005
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2009 - 01/2002
2Keratins (Keratin)IBA
08/2008 - 09/2007
2ImmunosorbentsIBA
08/2007 - 01/2002
2Polyglactin 910IBA
12/2004 - 08/2004
1Cholinesterases (Cholinesterase)IBA
05/2023
1Chelating AgentsIBA
05/2023
12-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA
05/2023
1Free Radical ScavengersIBA
05/2023
1AcetylcholinesteraseIBA
05/2023
1Trace Elements (Biometals)IBA
05/2023
1Oxidoreductases (Dehydrogenase)IBA
05/2023
1Cisplatin (Platino)FDA LinkGeneric
01/2023
1atezolizumabIBA
01/2023
1Endocrine DisruptorsIBA
03/2022
1Integrin alphaVbeta3IBA
03/2022
1TriazolesIBA
01/2022
1DioxinsIBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1Immune Checkpoint ProteinsIBA
01/2022

Therapy/Procedure

25Therapeutics
05/2023 - 08/2004
4Immunotherapy
03/2020 - 01/2018
3Drug Therapy (Chemotherapy)
01/2023 - 04/2015